Showing 12,241 - 12,260 results of 67,179 for search '(( 50 ((nn decrease) OR (a decrease)) ) OR ( 10 ((nm decrease) OR (mean decrease)) ))', query time: 1.27s Refine Results
  1. 12241
  2. 12242
  3. 12243
  4. 12244
  5. 12245
  6. 12246

    Quality of life in individuals with spinocerebellar ataxia type 10: a preliminary study by Laudiane Reis Santos (5762018)

    Published 2018
    “…Methods: This study focused on the disease duration, ataxia severity (SARA), balance (Berg Balance Scale), functionality (FIM, Lawton IADL) and QoL (SF-36 v.2) of 15 individuals with SCA10. Results: The population sample consisted of eight females and seven males, with a mean age of 43.8 (± 8.2) years, mean age of symptom onset of 33.1 (± 8.9) years and mean disease duration of 9.8 (± 11.2) years. …”
  7. 12247
  8. 12248

    In vivo assessment of YM155 using a patient-derived RCC xenograft model in SCID mice. by Mei Yi Sim (4067998)

    Published 2017
    “…(A) The mean tumour volume of vehicle- and YM155- treated mice at the given time-points showed a decrease in the rate of tumour growth at higher doses of YM155. …”
  9. 12249
  10. 12250
  11. 12251
  12. 12252
  13. 12253

    LIN-2 and FRM-3 regulate the synaptic abundance but not surface expression level of AChRs. by Lei Li (29537)

    Published 2022
    “…Representative images (A, C, scale bar 10 μm) and mean puncta intensity (B, D) are shown. …”
  14. 12254
  15. 12255
  16. 12256
  17. 12257
  18. 12258

    Shrimp allergen extract (SAE) immunotherapy preventing the development of allergies. by Honey Dzikri Marhaeny (20480031)

    Published 2024
    “…<p>Sensitized mice, but not the NC group, were treated (i.p.) with high- to low-dose immunotherapy (10 μg SAE for LI, 50 μg SAE for MI, and 100 μg SAE for HI). …”
  19. 12259
  20. 12260